Association of Metabolic Syndrome with Early Renal Dysfunction in Patients with Type 2 Diabetes Mellitus: A Hospital-Based Cross-Sectional Study.
Original Article
DOI:
https://doi.org/10.64911/r14ajm39Keywords:
Type 2 diabetes mellitus, metabolic syndrome, estimated glomerular filtration rate.Abstract
Objective: To determine the association between metabolic syndrome and early renal dysfunction among patients with type 2 diabetes mellitus attending a tertiary-care hospital in Pakistan.
Methodology: This Cross-sectional study was conducted at Bakhtawar Amin Hospital in Multan from January 2024 to December 2025. We enrolled 204 adults with type 2 diabetes using consecutive sampling. Metabolic syndrome was diagnosed using harmonized criteria. We defined early renal dysfunction as a urinary albumin-to-creatinine ratio of 30–300 mg/g and/or an estimated glomerular filtration rate of 60–89 mL/min/1.73 m². We excluded patients with established chronic kidney disease, acute kidney injury, or non-diabetic renal disease. We used multivariable logistic regression to identify factors independently associated with early renal dysfunction.
Results: The mean age was 52.6±9.8 years, and 112 (54.9%) participants were women. Metabolic syndrome was present in 142 (69.6%) patients, while early renal dysfunction was detected in 78 (38.2%). Renal dysfunction was more common among patients with metabolic syndrome than among those without it (45.8% versus 21.0%; p<0.001). Metabolic syndrome remained independently associated with early renal dysfunction after adjustment for relevant variables (adjusted odds ratio 2.54; 95% confidence interval 1.23–5.24). Longer diabetes duration, hypertension, and poor glycemic control were also independent predictors.
Conclusion: Metabolic syndrome was common and was independently associated with early renal dysfunction. Affordable metabolic and renal screening should be incorporated into routine diabetes care.
Published
Issue
Section
License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.





